Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Southwest Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of chemical raw materials and finished dosage forms. The company is a significant producer of anti-infective agents, including various antibiotics and synthetic antibacterials, serving both domestic and international markets. Its product portfolio encompasses a wide range of therapeutic categories such as respiratory, gastrointestinal, and cardiovascular health. With a focus on Good Manufacturing Practice (GMP) standards, the company operates extensive production facilities in the Sichuan province to ensure high-quality supply for healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Southwest Pharmaceutical.